Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04035590 | Seroma Reduction and Drain Free Mastectomy(SARA) | unknown | N/A | 250 | Zuyderland Medisch CentrumOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT05509829 | EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery(LAUREN) | unknown | N/A | 300 | Zuyderland Medisch CentrumOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT02679040 | Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy(HIST-RIC) | unknown | Phase 2 | 101 | Institut Paoli-CalmettesOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT04928014 | Validation of a Tear-based Screening Assay for Breast Cancer | unknown | — | 205 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05223218 | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | unknown | — | 500 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05830461 | Online Psychological Care Program for Women Who Attend a Breast Clinic. | unknown | N/A | 50 | University of GuadalajaraOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05927779 | Study of TFX06 in Women With Advanced Breast Cancer. | unknown | Phase 1 / Phase 2 | 74 | Zhejiang Yangli Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT01579734 | Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users(HOT) | unknown | Phase 3 | 1,884 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03920488 | Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer(PERSONA) | unknown | — | 264 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03939156 | Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer(ELENA) | unknown | — | 450 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04304352 | Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients(VEX) | unknown | Phase 2 | 162 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04365803 | Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial)(BETTY) | unknown | — | 22 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT05095675 | Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back(BOUNCE) | unknown | — | 660 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04689529 | Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer(PUMP) | unknown | N/A | 360 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05919498 | Realistic Evaluation of a Job Retention Program After Breast Cancer(RECOVA-FTRACS) | unknown | — | 215 | Hospices Civils de LyonOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT04610528 | A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression(TOT-HER3) | unknown | Early Phase 1 | 80 | SOLTI Breast Cancer Research GroupOTHER | 1 | Jun 23, 2023 | clinicaltrials |
| NCT05917444 | Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden. | unknown | — | 224 | National Taiwan University HospitalOTHER | 1 | Jun 23, 2023 | clinicaltrials |
| NCT05911867 | Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery Patients(MWMMET) | unknown | N/A | 108 | Cairo UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05914168 | Clinical Data Collection in Breast Tomosynthesis (COBRIS)(COBRIS) | unknown | N/A | 150 | GE HealthcareINDUSTRY | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05914402 | Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET(NeoaPET) | unknown | N/A | 100 | Fudan UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05914415 | The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy | unknown | N/A | 70 | Saglik Bilimleri UniversitesiOTHER | 0 | Jun 22, 2023 | clinicaltrials |
| NCT05914753 | Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer | unknown | N/A | 200 | Zhejiang Provincial People's HospitalOTHER | 0 | Jun 22, 2023 | clinicaltrials |
| NCT05910710 | Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer | unknown | — | 50 | Samsung Medical CenterOTHER | 1 | Jun 20, 2023 | clinicaltrials |
| NCT05726604 | 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy(RD3D4) | unknown | N/A | 15 | Central Hospital Saint QuentinOTHER_GOV | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05780307 | IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors | unknown | Phase 1 | 48 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05892146 | Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction | unknown | N/A | 100 | National Cheng-Kung University HospitalOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05892380 | The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast Lessions | unknown | — | 800 | Fudan UniversityOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05760183 | Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Jun 5, 2023 | clinicaltrials |
| NCT05584163 | Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves | unknown | N/A | 72 | Ewha Womans University Mokdong HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05885776 | Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research(PYTHON) | unknown | Phase 2 | 48 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05887154 | Non Surgical Treatment (Microwave Ablation) of Breast Cancer(MASTER) | unknown | N/A | 15 | University Medical Center GroningenOTHER | 0 | Jun 2, 2023 | clinicaltrials |
| NCT03567720 | Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC | unknown | Phase 2 | 65 | OncoSec Medical IncorporatedINDUSTRY | 2 | Jun 1, 2023 | clinicaltrials |
| NCT04500262 | Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes(COMPULSE) | unknown | N/A | 479 | NeoDynamics ABINDUSTRY | 1 | Jun 1, 2023 | clinicaltrials |
| NCT04510532 | Early Detection of CMP in Patients With Breast Cancer Using Cardiac Magnetic Resonance | unknown | — | 300 | RenJi HospitalOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT04265937 | ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies(SIGHT) | unknown | — | 5,000 | Fudan UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05689398 | Rehabilitation on Equal Terms - The ReMig Study | unknown | — | 140 | Lund UniversityOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05882019 | Evaluation of the Bexa™ Breast Examination (BBE) | unknown | N/A | 700 | Sure, Inc.INDUSTRY | 0 | May 31, 2023 | clinicaltrials |
| NCT05880927 | Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer | unknown | Phase 2 | 150 | Taizhou HospitalOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05878678 | Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position | unknown | Phase 2 | 200 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT05302778 | Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer(HERMIONE-10) | unknown | — | 200 | University of Milano BicoccaOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05872412 | Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer | unknown | Phase 2 | 82 | Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05876728 | Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer | unknown | — | 100 | Sohag UniversityOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05873036 | Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer Surgery | unknown | N/A | 74 | Superior UniversityOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT03383835 | Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer | unknown | N/A | 11 | Lauren NyeOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05870813 | CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer(CLEAR-B) | unknown | — | 3,000 | Institut fuer FrauengesundheitOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05868252 | Molecular Analysis of the Sloane Project | unknown | — | 1,500 | King's College LondonOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT05763992 | Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial(BREAKFAST-2) | unknown | Phase 2 | 145 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05135104 | Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period(PALBO) | unknown | — | 650 | Asociatia Oncohelp - Centrul de Oncologie OncohelpOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05861635 | The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression | unknown | Phase 4 | 42 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | May 17, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Jul 7, 2023source: clinicaltrials